Together, the clinical data as well as the in vitro and in vivo results revealed a positive TR4 role in PCa metastasis, which may function through CCL2 signaling, and targeting the TR4-CCL2 axis may become a new therapeutic approach to battle PCa metastasis (24). The gene discussed is NR2C2; the disease is posterior cortical atrophy.